- Home
- VRE vs IMTX Comparison
VRE vs IMTX Comparison
Compare VRE & IMTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRE
- IMTX
- Stock Information
- Founded
- VRE 1949
- IMTX N/A
- Country
- VRE United States
- IMTX Germany
- Employees
- VRE N/A
- IMTX N/A
- Industry
- VRE Real Estate Investment Trusts
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VRE Real Estate
- IMTX Health Care
- Exchange
- VRE Nasdaq
- IMTX Nasdaq
- Market Cap
- VRE 1.5B
- IMTX 1.1B
- IPO Year
- VRE 1994
- IMTX N/A
- Fundamental
- Price
- VRE $17.06
- IMTX $11.73
- Analyst Decision
- VRE Hold
- IMTX Strong Buy
- Analyst Count
- VRE 3
- IMTX 2
- Target Price
- VRE $15.33
- IMTX $16.00
- AVG Volume (30 Days)
- VRE 431.9K
- IMTX 328.3K
- Earning Date
- VRE 10-23-2024
- IMTX 08-13-2024
- Dividend Yield
- VRE 1.64%
- IMTX N/A
- EPS Growth
- VRE N/A
- IMTX N/A
- EPS
- VRE N/A
- IMTX N/A
- Revenue
- VRE $292,145,000.00
- IMTX $75,935,926.00
- Revenue This Year
- VRE N/A
- IMTX $42.78
- Revenue Next Year
- VRE $5.00
- IMTX N/A
- P/E Ratio
- VRE N/A
- IMTX N/A
- Revenue Growth
- VRE 12.90
- IMTX N/A
- 52 Week Low
- VRE $13.07
- IMTX $7.15
- 52 Week High
- VRE $18.14
- IMTX $13.77
- Technical
- Relative Strength Index (RSI)
- VRE 60.50
- IMTX 55.36
- Support Level
- VRE $17.19
- IMTX $10.83
- Resistance Level
- VRE $17.65
- IMTX $11.16
- Average True Range (ATR)
- VRE 0.29
- IMTX 0.40
- MACD
- VRE 0.01
- IMTX 0.06
- Stochastic Oscillator
- VRE 51.85
- IMTX 84.11
About VRE Veris Residential Inc.
Veris Residential Inc is a fully-integrated, self-administered and self-managed real estate investment trust (REIT). The company owns and operates a real estate portfolio comprised predominantly of multifamily rental properties located mainly in the Northeast and Class A office properties. The company performs substantially all real estate management, leasing, acquisition and development on an in-house basis. The properties are in three states in the Northeast, plus the District of Columbia. The company operates in two industry segments multifamily real estate & services and commercial & other real estate. The majority of revenue is from Multifamily real estate services.
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.